Genomics of Drug Sensitivity in Cancer NVP-TAE684
Synonyms NVP-TAE 684, TAE684, TAE-684
Targets ALK
Target pathway RTK signaling
PubCHEM ID 16038120
Jsmol
Download molecule 16038120
PUBCHEM IUPAC INCHI InChI=1S/C30H40ClN7O3S/c1-21(2)42(39,40)28-8-6-5-7-26(28)33-29-24(31)20-32-30(35-29)34-25-10-9-23(19-27(25)41-4)37-13-11-22(12-14-37)38-17-15-36(3)16-18-38/h5-10,19-22H,11-18H2,1-4H3,(H2,32,33,34,35)
Smiles ClC4(=C(N=C(NC3(=C(OC)C=C(N2(CCC(N1(CCN(C)CC1))CC2))C=C3))N=C4)NC5(=C(S(=O)(=O)C(C)C)C=CC=C5))
Cluster number 58
calculated LogS -5,955
Molecular weight 614,213
calculated LogP 4,599
H-Acceptors 10
H-Donors 2
Ro5 violations 1
Druglikeness 3,8491
DrugScore 0,116708888789735
Mutagenic high
Tumorigenic low
Reproductive Effective low
Irritant none
Fish Toxicity High FHMT
Fish Toxicity2 1,3571
Rat Acute Toxicity 2,5352
Acute Oral Toxicity III
Caco-2 Permeability Caco2-
Caco-2 Permeability2 1,1642
P-glycoprotein Substrate Substrate
P-glycoprotein Inhibitor Non-inhibitor
P-glycoprotein Inhibitor2 Non-inhibitor
Human Ether-a-go-go-Related Gene Inhibition Weak inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,5673
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Substrate
CYP450 3A4 Inhibitor Inhibitor
CYP450 2C19 Inhibitor Non-inhibitor
CYP450 2C9 Inhibitor Non-inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Non-inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB-
CYP Inhibitory Promiscuity High CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Non-inhibitor
Subcellular localization Lysosome
Human Intestinal Absorption HIA+
Aqueous solubility -3,9056
Information useful only for research purposes.